APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IVD CDMO

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global IVD CDMO Market Analysis and Forecast 2026-2032

Report ID 174171740216 April 2026248 pages

Choose your research edition.

Industry ResearchIVD CDMO Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal IVD CDMO Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal IVD CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IVD CDMO Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal IVD CDMO Market Analysis and Forecast 2026-2032248 pages · $4,950 USD

Market perspective

The global IVD CDMO market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for IVD CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for IVD CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for IVD CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for IVD CDMO is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of IVD CDMO include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut and Erreka, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for IVD CDMO, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of IVD CDMO, also provides the revenue of main regions and countries. Of the upcoming market potential for IVD CDMO, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IVD CDMO revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IVD CDMO market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for IVD CDMO revenue, projected growth trends, production technology, application and end-user industry.

IVD CDMO Segment by Company

Hitachi

Canon

TE Connectivity

JEOL

HU Group

DCN DX

Stevanato

Argonaut

Erreka

GBC

Phillips Medisize

AIVD Biotech

Kaishi Biological Technology

Keysmile Biological Technology

Nabai Medical Technology

Hochuen Medical

IVD CDMO Segment by Type

Molecular Diagnosis

Immunodiagnosis

Biochemical Diagnosis

Other

IVD CDMO Segment by Application

Instruments

Consumables

IVD CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVD CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of IVD CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of IVD CDMO company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IVD CDMO revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IVD CDMO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Molecular Diagnosis Major Player Table 3. Immunodiagnosis Major Player Table 4. Biochemical Diagnosis Major Player Table 5. Other Major Player Table 6. Global IVD CDMO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Instruments Major Player Table 8. Consumables Major Player Table 9. IVD CDMO Industry Trends Table 10. IVD CDMO Industry Drivers Table 11. IVD CDMO Industry Opportunities and Challenges Table 12. IVD CDMO Industry Restraints Table 13. Global IVD CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global IVD CDMO Market Size by Region (2021-2026) & (US$ Million) Table 15. Global IVD CDMO Market Share by Region (2021-2026) Table 16. Global IVD CDMO Market Size by Region (2027-2032) & (US$ Million) Table 17. Global IVD CDMO Market Share by Region (2027-2032) Table 18. Global IVD CDMO Revenue by Players (US$ Million) & (2021-2026) Table 19. Global IVD CDMO Revenue Market Share by Players (2021-2026) Table 20. Global IVD CDMO Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global IVD CDMO Key Players Headquarters & Area Served Table 22. Global IVD CDMO Players, Product Type & Application Table 23. Global IVD CDMO Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global IVD CDMO by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global IVD CDMO Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global IVD CDMO Revenue by Type (2021-2026) & (US$ Million) Table 28. Global IVD CDMO Revenue by Type (2027-2032) & (US$ Million) Table 29. Global IVD CDMO Revenue Market Share by Type (2021-2026) Table 30. Global IVD CDMO Revenue Market Share by Type (2027-2032) Table 31. Global IVD CDMO Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global IVD CDMO Revenue by Application (2021-2026) & (US$ Million) Table 33. Global IVD CDMO Revenue by Application (2027-2032) & (US$ Million) Table 34. Global IVD CDMO Revenue Market Share by Application (2021-2026) Table 35. Global IVD CDMO Revenue Market Share by Application (2027-2032) Table 36. Hitachi Company Information Table 37. Hitachi Business Overview Table 38. Hitachi IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Hitachi IVD CDMO Product Portfolio Table 40. Hitachi Recent Development Table 41. Canon Company Information Table 42. Canon Business Overview Table 43. Canon IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Canon IVD CDMO Product Portfolio Table 45. Canon Recent Development Table 46. TE Connectivity Company Information Table 47. TE Connectivity Business Overview Table 48. TE Connectivity IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. TE Connectivity IVD CDMO Product Portfolio Table 50. TE Connectivity Recent Development Table 51. JEOL Company Information Table 52. JEOL Business Overview Table 53. JEOL IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. JEOL IVD CDMO Product Portfolio Table 55. JEOL Recent Development Table 56. HU Group Company Information Table 57. HU Group Business Overview Table 58. HU Group IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. HU Group IVD CDMO Product Portfolio Table 60. HU Group Recent Development Table 61. DCN DX Company Information Table 62. DCN DX Business Overview Table 63. DCN DX IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. DCN DX IVD CDMO Product Portfolio Table 65. DCN DX Recent Development Table 66. Stevanato Company Information Table 67. Stevanato Business Overview Table 68. Stevanato IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Stevanato IVD CDMO Product Portfolio Table 70. Stevanato Recent Development Table 71. Argonaut Company Information Table 72. Argonaut Business Overview Table 73. Argonaut IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Argonaut IVD CDMO Product Portfolio Table 75. Argonaut Recent Development Table 76. Erreka Company Information Table 77. Erreka Business Overview Table 78. Erreka IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Erreka IVD CDMO Product Portfolio Table 80. Erreka Recent Development Table 81. GBC Company Information Table 82. GBC Business Overview Table 83. GBC IVD CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. GBC IVD CDMO Product Portfolio Table 85. GBC Recent Development Table 86. Phillips Medisize Company Information Table 87. Phillips Medisize Business Overview Table 88. Phillips Medisize IVD CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Phillips Medisize IVD CDMO Product Portfolio Table 90. Phillips Medisize Recent Development Table 91. AIVD Biotech Company Information Table 92. AIVD Biotech Business Overview Table 93. AIVD Biotech IVD CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. AIVD Biotech IVD CDMO Product Portfolio Table 95. AIVD Biotech Recent Development Table 96. Kaishi Biological Technology Company Information Table 97. Kaishi Biological Technology Business Overview Table 98. Kaishi Biological Technology IVD CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Kaishi Biological Technology IVD CDMO Product Portfolio Table 100. Kaishi Biological Technology Recent Development Table 101. Keysmile Biological Technology Company Information Table 102. Keysmile Biological Technology Business Overview Table 103. Keysmile Biological Technology IVD CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Keysmile Biological Technology IVD CDMO Product Portfolio Table 105. Keysmile Biological Technology Recent Development Table 106. Nabai Medical Technology Company Information Table 107. Nabai Medical Technology Business Overview Table 108. Nabai Medical Technology IVD CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Nabai Medical Technology IVD CDMO Product Portfolio Table 110. Nabai Medical Technology Recent Development Table 111. Hochuen Medical Company Information Table 112. Hochuen Medical Business Overview Table 113. Hochuen Medical IVD CDMO Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Hochuen Medical IVD CDMO Product Portfolio Table 115. Hochuen Medical Recent Development Table 116. North America IVD CDMO Revenue by Type (2021-2026) & (US$ Million) Table 117. North America IVD CDMO Revenue by Type (2027-2032) & (US$ Million) Table 118. North America IVD CDMO Revenue by Application (2021-2026) & (US$ Million) Table 119. North America IVD CDMO Revenue by Application (2027-2032) & (US$ Million) Table 120. North America IVD CDMO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America IVD CDMO Revenue by Country (2021-2026) & (US$ Million) Table 122. North America IVD CDMO Revenue by Country (US$ Million) & (2027-2032) Table 123. Europe IVD CDMO Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe IVD CDMO Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe IVD CDMO Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe IVD CDMO Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe IVD CDMO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe IVD CDMO Revenue by Country (2021-2026) & (US$ Million) Table 129. Europe IVD CDMO Revenue by Country (US$ Million) & (2027-2032) Table 130. China IVD CDMO Revenue by Type (2021-2026) & (US$ Million) Table 131. China IVD CDMO Revenue by Type (2027-2032) & (US$ Million) Table 132. China IVD CDMO Revenue by Application (2021-2026) & (US$ Million) Table 133. China IVD CDMO Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia IVD CDMO Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia IVD CDMO Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia IVD CDMO Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia IVD CDMO Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia IVD CDMO Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia IVD CDMO Revenue by Region (US$ Million) & (2021-2026) Table 140. Asia IVD CDMO Revenue by Region (US$ Million) & (2027-2032) Table 141. SAMEA IVD CDMO Revenue by Type (2021-2026) & (US$ Million) Table 142. SAMEA IVD CDMO Revenue by Type (2027-2032) & (US$ Million) Table 143. SAMEA IVD CDMO Revenue by Application (2021-2026) & (US$ Million) Table 144. SAMEA IVD CDMO Revenue by Application (2027-2032) & (US$ Million) Table 145. SAMEA IVD CDMO Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. SAMEA IVD CDMO Revenue by Country (2021-2026) & (US$ Million) Table 147. SAMEA IVD CDMO Revenue by Country (US$ Million) & (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. IVD CDMO Image Figure 2. Global IVD CDMO Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IVD CDMO Market Size Share 2021 VS 2025 VS 2032 Figure 4. Molecular Diagnosis Image Figure 5. Immunodiagnosis Image Figure 6. Biochemical Diagnosis Image Figure 7. Other Image Figure 8. Global IVD CDMO Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global IVD CDMO Market Size Share 2021 VS 2025 VS 2032 Figure 10. Instruments Image Figure 11. Consumables Image Figure 12. Global IVD CDMO Market Size (US$ Million) & (2021-2032) Figure 13. Global IVD CDMO Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global IVD CDMO Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global IVD CDMO Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global IVD CDMO Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global IVD CDMO Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global IVD CDMO Revenue Market Share by Type (2021-2032) Figure 20. Global IVD CDMO Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global IVD CDMO Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global IVD CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America IVD CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America IVD CDMO Revenue Share by Type (2021-2032) Figure 25. North America IVD CDMO Revenue Share by Application (2021-2032) Figure 26. North America IVD CDMO Revenue Share by Country (2021-2032) Figure 27. United States IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe IVD CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe IVD CDMO Revenue Share by Type (2021-2032) Figure 32. Europe IVD CDMO Revenue Share by Application (2021-2032) Figure 33. Europe IVD CDMO Revenue Share by Country (2021-2032) Figure 34. Germany IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China IVD CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China IVD CDMO Revenue Share by Type (2021-2032) Figure 44. China IVD CDMO Revenue Share by Application (2021-2032) Figure 45. Asia IVD CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia IVD CDMO Revenue Share by Type (2021-2032) Figure 47. Asia IVD CDMO Revenue Share by Application (2021-2032) Figure 48. Asia IVD CDMO Revenue Share by Region (2021-2032) Figure 49. Japan IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA IVD CDMO Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA IVD CDMO Revenue Share by Type (2021-2032) Figure 57. SAMEA IVD CDMO Revenue Share by Application (2021-2032) Figure 58. SAMEA IVD CDMO Revenue Share by Country (2021-2032) Figure 59. Brazil IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt IVD CDMO Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Diagnosis
  • Immunodiagnosis
  • Biochemical Diagnosis
  • Other
Applications
  • Instruments
  • Consumables
Companies covered
  • Hitachi
  • Canon
  • TE Connectivity
  • JEOL
  • HU Group
  • DCN DX
  • Stevanato
  • Argonaut
  • Erreka
  • GBC
  • Phillips Medisize
  • AIVD Biotech
  • Kaishi Biological Technology
  • Keysmile Biological Technology
  • Nabai Medical Technology
  • Hochuen Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 IVD CDMO Market by Type
  3. 1.2.1 Global IVD CDMO Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Molecular Diagnosis
  5. 1.2.3 Immunodiagnosis
  6. 1.2.4 Biochemical Diagnosis
  7. 1.2.5 Other
  8. 1.3 IVD CDMO Market by Application
  9. 1.3.1 Global IVD CDMO Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Instruments
  11. 1.3.3 Consumables
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 IVD CDMO Market Dynamics
  1. 2.1 IVD CDMO Industry Trends
  2. 2.2 IVD CDMO Industry Drivers
  3. 2.3 IVD CDMO Industry Opportunities and Challenges
  4. 2.4 IVD CDMO Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global IVD CDMO Market Perspective (2021-2032)
  2. 3.2 Global IVD CDMO Growth Trends by Region
  3. 3.2.1 Global IVD CDMO Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global IVD CDMO Market Size by Region (2021-2026)
  5. 3.2.3 Global IVD CDMO Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global IVD CDMO Revenue by Players
  2. 4.1.1 Global IVD CDMO Revenue by Players (2021-2026)
  3. 4.1.2 Global IVD CDMO Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global IVD CDMO Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global IVD CDMO Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global IVD CDMO Key Players Headquarters & Area Served
  7. 4.4 Global IVD CDMO Players, Product Type & Application
  8. 4.5 Global IVD CDMO Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global IVD CDMO Market CR5 and HHI
  11. 4.6.3 2025 IVD CDMO Tier 1, Tier 2, and Tier 3
5 IVD CDMO Market Size by Type
  1. 5.1 Global IVD CDMO Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global IVD CDMO Revenue by Type (2021-2032)
  3. 5.3 Global IVD CDMO Revenue Market Share by Type (2021-2032)
6 IVD CDMO Market Size by Application
  1. 6.1 Global IVD CDMO Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global IVD CDMO Revenue by Application (2021-2032)
  3. 6.3 Global IVD CDMO Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hitachi
  2. 7.1.1 Hitachi Company Information
  3. 7.1.2 Hitachi Business Overview
  4. 7.1.3 Hitachi IVD CDMO Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hitachi IVD CDMO Product Portfolio
  6. 7.1.5 Hitachi Recent Developments
  7. 7.2 Canon
  8. 7.2.1 Canon Company Information
  9. 7.2.2 Canon Business Overview
  10. 7.2.3 Canon IVD CDMO Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Canon IVD CDMO Product Portfolio
  12. 7.2.5 Canon Recent Developments
  13. 7.3 TE Connectivity
  14. 7.3.1 TE Connectivity Company Information
  15. 7.3.2 TE Connectivity Business Overview
  16. 7.3.3 TE Connectivity IVD CDMO Revenue and Gross Margin (2021-2026)
  17. 7.3.4 TE Connectivity IVD CDMO Product Portfolio
  18. 7.3.5 TE Connectivity Recent Developments
  19. 7.4 JEOL
  20. 7.4.1 JEOL Company Information
  21. 7.4.2 JEOL Business Overview
  22. 7.4.3 JEOL IVD CDMO Revenue and Gross Margin (2021-2026)
  23. 7.4.4 JEOL IVD CDMO Product Portfolio
  24. 7.4.5 JEOL Recent Developments
  25. 7.5 HU Group
  26. 7.5.1 HU Group Company Information
  27. 7.5.2 HU Group Business Overview
  28. 7.5.3 HU Group IVD CDMO Revenue and Gross Margin (2021-2026)
  29. 7.5.4 HU Group IVD CDMO Product Portfolio
  30. 7.5.5 HU Group Recent Developments
  31. 7.6 DCN DX
  32. 7.6.1 DCN DX Company Information
  33. 7.6.2 DCN DX Business Overview
  34. 7.6.3 DCN DX IVD CDMO Revenue and Gross Margin (2021-2026)
  35. 7.6.4 DCN DX IVD CDMO Product Portfolio
  36. 7.6.5 DCN DX Recent Developments
  37. 7.7 Stevanato
  38. 7.7.1 Stevanato Company Information
  39. 7.7.2 Stevanato Business Overview
  40. 7.7.3 Stevanato IVD CDMO Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Stevanato IVD CDMO Product Portfolio
  42. 7.7.5 Stevanato Recent Developments
  43. 7.8 Argonaut
  44. 7.8.1 Argonaut Company Information
  45. 7.8.2 Argonaut Business Overview
  46. 7.8.3 Argonaut IVD CDMO Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Argonaut IVD CDMO Product Portfolio
  48. 7.8.5 Argonaut Recent Developments
  49. 7.9 Erreka
  50. 7.9.1 Erreka Company Information
  51. 7.9.2 Erreka Business Overview
  52. 7.9.3 Erreka IVD CDMO Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Erreka IVD CDMO Product Portfolio
  54. 7.9.5 Erreka Recent Developments
  55. 7.10 GBC
  56. 7.10.1 GBC Company Information
  57. 7.10.2 GBC Business Overview
  58. 7.10.3 GBC IVD CDMO Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GBC IVD CDMO Product Portfolio
  60. 7.10.5 GBC Recent Developments
  61. 7.11 Phillips Medisize
  62. 7.11.1 Phillips Medisize Company Information
  63. 7.11.2 Phillips Medisize Business Overview
  64. 7.11.3 Phillips Medisize IVD CDMO Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Phillips Medisize IVD CDMO Product Portfolio
  66. 7.11.5 Phillips Medisize Recent Developments
  67. 7.12 AIVD Biotech
  68. 7.12.1 AIVD Biotech Company Information
  69. 7.12.2 AIVD Biotech Business Overview
  70. 7.12.3 AIVD Biotech IVD CDMO Revenue and Gross Margin (2021-2026)
  71. 7.12.4 AIVD Biotech IVD CDMO Product Portfolio
  72. 7.12.5 AIVD Biotech Recent Developments
  73. 7.13 Kaishi Biological Technology
  74. 7.13.1 Kaishi Biological Technology Company Information
  75. 7.13.2 Kaishi Biological Technology Business Overview
  76. 7.13.3 Kaishi Biological Technology IVD CDMO Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Kaishi Biological Technology IVD CDMO Product Portfolio
  78. 7.13.5 Kaishi Biological Technology Recent Developments
  79. 7.14 Keysmile Biological Technology
  80. 7.14.1 Keysmile Biological Technology Company Information
  81. 7.14.2 Keysmile Biological Technology Business Overview
  82. 7.14.3 Keysmile Biological Technology IVD CDMO Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Keysmile Biological Technology IVD CDMO Product Portfolio
  84. 7.14.5 Keysmile Biological Technology Recent Developments
  85. 7.15 Nabai Medical Technology
  86. 7.15.1 Nabai Medical Technology Company Information
  87. 7.15.2 Nabai Medical Technology Business Overview
  88. 7.15.3 Nabai Medical Technology IVD CDMO Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Nabai Medical Technology IVD CDMO Product Portfolio
  90. 7.15.5 Nabai Medical Technology Recent Developments
  91. 7.16 Hochuen Medical
  92. 7.16.1 Hochuen Medical Company Information
  93. 7.16.2 Hochuen Medical Business Overview
  94. 7.16.3 Hochuen Medical IVD CDMO Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Hochuen Medical IVD CDMO Product Portfolio
  96. 7.16.5 Hochuen Medical Recent Developments
8 North America
  1. 8.1 North America IVD CDMO Revenue (2021-2032)
  2. 8.2 North America IVD CDMO Revenue by Type (2021-2032)
  3. 8.2.1 North America IVD CDMO Revenue by Type (2021-2026)
  4. 8.2.2 North America IVD CDMO Revenue by Type (2027-2032)
  5. 8.3 North America IVD CDMO Revenue Share by Type (2021-2032)
  6. 8.4 North America IVD CDMO Revenue by Application (2021-2032)
  7. 8.4.1 North America IVD CDMO Revenue by Application (2021-2026)
  8. 8.4.2 North America IVD CDMO Revenue by Application (2027-2032)
  9. 8.5 North America IVD CDMO Revenue Share by Application (2021-2032)
  10. 8.6 North America IVD CDMO Revenue by Country
  11. 8.6.1 North America IVD CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America IVD CDMO Revenue by Country (2021-2026)
  13. 8.6.3 North America IVD CDMO Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe IVD CDMO Revenue (2021-2032)
  2. 9.2 Europe IVD CDMO Revenue by Type (2021-2032)
  3. 9.2.1 Europe IVD CDMO Revenue by Type (2021-2026)
  4. 9.2.2 Europe IVD CDMO Revenue by Type (2027-2032)
  5. 9.3 Europe IVD CDMO Revenue Share by Type (2021-2032)
  6. 9.4 Europe IVD CDMO Revenue by Application (2021-2032)
  7. 9.4.1 Europe IVD CDMO Revenue by Application (2021-2026)
  8. 9.4.2 Europe IVD CDMO Revenue by Application (2027-2032)
  9. 9.5 Europe IVD CDMO Revenue Share by Application (2021-2032)
  10. 9.6 Europe IVD CDMO Revenue by Country
  11. 9.6.1 Europe IVD CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe IVD CDMO Revenue by Country (2021-2026)
  13. 9.6.3 Europe IVD CDMO Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China IVD CDMO Revenue (2021-2032)
  2. 10.2 China IVD CDMO Revenue by Type (2021-2032)
  3. 10.2.1 China IVD CDMO Revenue by Type (2021-2026)
  4. 10.2.2 China IVD CDMO Revenue by Type (2027-2032)
  5. 10.3 China IVD CDMO Revenue Share by Type (2021-2032)
  6. 10.4 China IVD CDMO Revenue by Application (2021-2032)
  7. 10.4.1 China IVD CDMO Revenue by Application (2021-2026)
  8. 10.4.2 China IVD CDMO Revenue by Application (2027-2032)
  9. 10.5 China IVD CDMO Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia IVD CDMO Revenue (2021-2032)
  2. 11.2 Asia IVD CDMO Revenue by Type (2021-2032)
  3. 11.2.1 Asia IVD CDMO Revenue by Type (2021-2026)
  4. 11.2.2 Asia IVD CDMO Revenue by Type (2027-2032)
  5. 11.3 Asia IVD CDMO Revenue Share by Type (2021-2032)
  6. 11.4 Asia IVD CDMO Revenue by Application (2021-2032)
  7. 11.4.1 Asia IVD CDMO Revenue by Application (2021-2026)
  8. 11.4.2 Asia IVD CDMO Revenue by Application (2027-2032)
  9. 11.5 Asia IVD CDMO Revenue Share by Application (2021-2032)
  10. 11.6 Asia IVD CDMO Revenue by Country
  11. 11.6.1 Asia IVD CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia IVD CDMO Revenue by Country (2021-2026)
  13. 11.6.3 Asia IVD CDMO Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA IVD CDMO Revenue (2021-2032)
  2. 12.2 SAMEA IVD CDMO Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA IVD CDMO Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA IVD CDMO Revenue by Type (2027-2032)
  5. 12.3 SAMEA IVD CDMO Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA IVD CDMO Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA IVD CDMO Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA IVD CDMO Revenue by Application (2027-2032)
  9. 12.5 SAMEA IVD CDMO Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA IVD CDMO Revenue by Country
  11. 12.6.1 SAMEA IVD CDMO Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA IVD CDMO Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA IVD CDMO Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst